Cost-Effectiveness Analysis of Crizanlizumab in Sickle Cell Disease in Iran
Background: Sickle cell disease (SCD) prevalence is predicted to rise dramatically in the upcoming years. Although several medications have received Food and Drug Administration (FDA) approval in recent years, low- and middle-income countries (LMICs) still struggle to access these medications due to...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shiraz University of Medical Sciences
2025-08-01
|
| Series: | Iranian Journal of Medical Sciences |
| Subjects: | |
| Online Access: | https://ijms.sums.ac.ir/article_51078_3ed130f6ad6d84cd2a423316653e315f.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|